U.S. market Closed. Opens in 3 hours 40 minutes

TAK | Takeda Pharmaceutical Company Limited Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for TAK we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is very weak.

Valuation (78%)

Company Industry
P/E Ratio (TTM) 22.20 17.23
PEG Ratio (TTM) 6.40 -32.93
P/S Ratio (TTM) 1.52 5.23
P/B Ratio (TTM) 0.43 4.53
P/FCF Ratio (TTM) 15.72 14.91
Price to 5YR AVG Earnings Ratio 0.10 24.57
Price to 5YR AVG FCF Ratio 0.08 18.08

Profitability (25%)

Company Industry
ROA (TTM) 0.92% 4.02%
ROE (TTM) 2.08% 27.89%
Net Profit Margin (TTM) 3.40% -9.55%
ROIC 5YR AVG 4.18% 12.32%

Growth (97%)

4QTR AVG 3YR AVG 5YR AVG
EPS 831.35% 219.50% 128.48%
Revenue 3.65% 21.90% 16.88%
Net Income 829.88% 217.21% 126.97%
Cash Flow 33.36% 55.31% 23.69%

Health (35%)

Company Industry
Current Ratio (TTM) 1.26 2.51
Quick Ratio (TTM) 0.74 1.87
D/E Ratio (TTM) 0.70 -0.07
Interest Coverage (TTM) 2.10 16.86
Piotroski F-Score 5 6
Altman Z-Score 0.49 4.41
LTL to 5YR AVG FCF 8.39 3.86
Shares Outstanding Growth 5YR AVG -3.71% 24.93%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙